- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 29, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A study published in a supplement to The American Journal of Managed Care® (AJMC®) was referenced in an article by Drug Store News. The study, “Medication-Related Problems Identified by Pharmacists in an Enhanced Medication Therapy Management Model,” showed that use of an advanced clinical decision support system helped pharmacists identify a substantial number of medication-related problems among Medicare Part D beneficiaries.
A piece by San Diego Jewish World cited an article from an AJMC® supplement, titled “Insomnia Overview: Epidemiology, Pathophysiology, Diagnosis and Monitoring, and Nonpharmacologic Therapy.” The overview article indicated that the unadjusted prevalence of insomnia or trouble sleeping increased by 8% over a decade, from 17.5% (37.5 million adults) in 2002 to 19.2% (46.2 million adults) in 2012.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Oral GC Dose Tapering for MG Linked to Efgartigimod Initiation
August 25th 2025Using US claims data, the authors evaluated oral glucocorticoid (GC) use at 5 time points during their retrospective analysis: 3 months before starting efgartigimod and 3, 6, 9, and 12 months after starting efgartigimod.
Read More
